Najat Daw, MD

Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Disclosure information not submitted.

Presentation(s):

• Paper 23 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED METASTATIC OSTEOSARCOMA: FINAL RESULTS

  Thursday, November 14, 2024
  1:45 PM – 3:15 PM PST

• Paper 63 - EXPLORING THE HETEROGENEITY OF DESMOPLASTIC SMALL ROUND CELL TUMORS THROUGH MULTI-OMICS ANALYSES UNCOVERS EPITHELIAL AND NEUROENDOCRINE LINEAGES

  Friday, November 15, 2024
  4:00 PM – 5:00 PM PST